Rang	Name	Position
1	Dr. Helen I. Torley M.B. Ch. B., M.R.C.P.	President, CEO & Director
2	Mr. Mark Snyder Esq.	Executive VP, General Counsel, Chief Compliance Officer & Corporate Secretary
3	Mr. Darren Snellgrove	Senior VP & CFO
4	Mr. Brian Sweeney	Chief Human Resources Officer
5	Mr. David A. Ramsay MBA	President of Drug Delivery
6	Dr. Christopher Wahl M.B.A., M.D.	Chief Scientific Officer
7	Dr. Charles P. Theuer M.D., Ph.D.	Chief Medical Officer
8	Mr. Paul Spence	Chief Commercial Officer
9	Mr. Rhys de Callier	Chief Strategy Officer
10	Mr. Chase Coffman Ph.D.	President of Hypercon

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	11,69%	1,73 Mrd. USD
2	Vanguard Capital Management, LLC	4,71%	0,70 Mrd. USD
3	Vanguard Portfolio Management, LLC	4,67%	0,69 Mrd. USD
4	State Street Corp	4,56%	0,67 Mrd. USD
5	Amvescap Plc.	2,80%	0,41 Mrd. USD
6	Morgan Stanley - Brokerage Accounts	2,50%	0,37 Mrd. USD
7	Boston Partners Global Investors, Inc	2,44%	0,36 Mrd. USD
8	Bank of America Corp	2,41%	0,36 Mrd. USD
9	Geode Capital Management, LLC	2,22%	0,33 Mrd. USD
10	William Blair Investment Management, LLC	2,21%	0,33 Mrd. USD
11	Snyder Capital Management LP	2,11%	0,31 Mrd. USD
12	Dimensional Fund Advisors, Inc.	1,84%	0,27 Mrd. USD
13	D. E. Shaw & Co LP	1,77%	0,26 Mrd. USD
14	Assenagon Asset Management SA	1,76%	0,26 Mrd. USD
15	Royal London Asset Management Ltd	1,60%	0,24 Mrd. USD
16	Arrowstreet Capital Limited Partnership	1,50%	0,22 Mrd. USD
17	AllianceBernstein L.P.	1,49%	0,22 Mrd. USD
18	Two Sigma Investments LLC	1,46%	0,22 Mrd. USD
19	UBS Group AG	1,31%	0,19 Mrd. USD
20	Fuller & Thaler Asset Management Inc	1,31%	0,19 Mrd. USD